Century Therapeutics (IPSC)
(Delayed Data from NSDQ)
$1.96 USD
-0.13 (-6.22%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $1.95 -0.01 (-0.51%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for Century Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -136.67 | -130.93 | -95.82 | -53.58 | NA |
Depreciation/Amortization & Depletion | 9.15 | 8.74 | 4.05 | 1.49 | NA |
Net Change from Assets/Liabilities | 9.38 | 123.95 | -2.80 | 4.86 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 29.79 | 12.30 | 5.57 | 5.95 | NA |
Net Cash From Operating Activities | -88.35 | 14.05 | -89.00 | -41.27 | NA |
Property & Equipment | -13.74 | -30.60 | -44.97 | -9.83 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | -4.72 | NA |
Investments | 74.87 | 17.48 | -253.37 | -8.21 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | 61.13 | -13.13 | -298.34 | -22.76 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.52 | 27.16 | 162.15 | 0.00 | NA |
Issuance (Repayment) of Debt | -10.24 | 0.00 | 0.00 | 9.73 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 0.00 | 255.63 | 37.96 | NA |
Net Cash from Financing Activities | -9.73 | 27.16 | 417.77 | 47.69 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -36.94 | 28.08 | 30.43 | -16.34 | NA |
Cash at Beginning of Period | 86.24 | 58.16 | 27.73 | 44.06 | NA |
Cash at End of Period | 49.30 | 86.24 | 58.16 | 27.73 | NA |
Diluted Net EPS | -2.30 | -2.27 | -2.96 | NA | NA |
Fiscal Year End for Century Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -28.06 | -136.67 | -97.28 | -64.56 |
Depreciation/Amortization & Depletion | NA | 2.11 | 9.15 | 9.59 | 6.24 |
Net Change from Assets/Liabilities | NA | -9.05 | 9.38 | 12.29 | 0.11 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 4.75 | 29.79 | 13.28 | 9.74 |
Net Cash From Operating Activities | NA | -30.25 | -88.35 | -62.12 | -48.47 |
Property & Equipment | NA | -0.54 | -13.74 | -12.76 | -9.49 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 12.08 | 74.87 | 55.29 | 47.80 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 11.54 | 61.13 | 42.53 | 38.31 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.37 | 0.52 | 0.87 | 0.57 |
Issuance (Repayment) of Debt | NA | 0.00 | -10.24 | -10.24 | -10.24 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 17.83 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 18.20 | -9.73 | -9.37 | -9.67 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -0.51 | -36.94 | -28.96 | -19.83 |
Cash at Beginning of Period | NA | 49.30 | 86.24 | 86.24 | 86.24 |
Cash at End of Period | NA | 48.79 | 49.30 | 57.29 | 66.42 |
Diluted Net EPS | NA | -0.45 | -0.66 | -0.55 | -0.56 |